阅读说明：本技术 用于治疗新型冠状病毒肺炎继发细菌感染性疾病的截短侧耳素类化合物 (Pleuromutilin compounds for treating novel bacterial infectious diseases secondary to coronavirus pneumonia ) 是由 袁莉莉 李少春 于 2020-04-20 设计创作，主要内容包括：本发明涉及新型截短侧耳素类化合物、它们的药物组合物及使用方法。此外,本发明还涉及用于治疗细菌感染的治疗方法,包括耐药性微生物造成的感染,包括多重耐药性微生物。本发明特别涉及用于治疗新型冠状病毒(COVID-19或SARS-Cov-2)肺炎继发细菌感染性疾病的方法和化合物及其药用组合物,为打赢新冠肺炎疫情防控阻击战提供科技支撑。(The present invention relates to novel pleuromutilin compounds, their pharmaceutical compositions and methods of use. In addition, the invention relates to therapeutic methods for treating bacterial infections, including infections caused by drug-resistant microorganisms, including multidrug-resistant microorganisms. The invention particularly relates to a method and a compound for treating a novel bacterial infectious disease secondary to coronavirus (COVID-19 or SARS-Cov-2) pneumonia and a medicinal composition thereof, and provides scientific support for winning new coronary pneumonia epidemic situation prevention and control fight.)